What Can Be Used Instead of Mesh for Prolapse?

Considering options for pelvic organ prolapse? Explore diverse treatment pathways and alternatives to mesh for informed choices.

Several well-studied alternatives to synthetic mesh exist for treating pelvic organ prolapse, ranging from surgical techniques that use your own tissue to non-surgical options like pessaries and pelvic floor training. The shift away from mesh has accelerated since regulatory actions in the late 2010s, but these alternatives are not new or experimental. Native tissue surgical repairs have decades of data behind them, pessaries predate modern surgery entirely, and newer approaches using your body’s own fascia as a graft are generating encouraging early results. The right choice depends on the severity of your prolapse, your age and health, whether you want to preserve sexual function, and how you weigh the tradeoffs between durability and risk.

Why the Move Away From Mesh

Synthetic polypropylene mesh was introduced to prolapse surgery to improve anatomical durability, and on that narrow measure it works: a Cochrane review found that recurrent prolapse visible on exam was significantly less likely after mesh repair compared to native tissue repair. But the same review found that about 12% of women who received mesh experienced mesh exposure through the vaginal wall, and roughly 6% needed additional surgery just to deal with that complication. When repeat surgeries for prolapse, stress incontinence, and mesh exposure were counted together, women in the mesh group were more likely to need another operation overall. A long-term randomized trial following women for 12 years found that 40% of those in the mesh group had undergone additional surgery, compared to 19% in the native tissue group.

These findings, along with reports of chronic pain, painful intercourse, and vaginal erosion, led the FDA to order manufacturers to stop selling transvaginal mesh kits for prolapse in 2019. Abdominal mesh procedures like sacrocolpopexy were not included in that order and remain in use, but many patients and surgeons are now interested in mesh-free options regardless of the surgical route. Here is what those options actually look like.

Native Tissue Repair

The most straightforward mesh alternative is simply repairing the prolapse with the tissue you already have. In an anterior colporrhaphy, for instance, the surgeon folds and stitches the weakened connective tissue layer between the bladder and vaginal wall to rebuild that support. Similar principles apply to posterior repair (for the rectum side) and to the various procedures that re-suspend the top of the vagina when it drops.

Success rates for native tissue repairs vary depending on how “success” is defined. If you measure by what shows up on a physical exam, mesh tends to look better. But if you ask women whether they still feel a bulge or have bothersome symptoms, native tissue repairs do nearly as well. Across 12 randomized trials comparing native tissue and mesh for anterior wall prolapse, symptomatic success rates were comparable: roughly 62–100% for native tissue versus 75–96% for mesh. The overall reoperation rate for native tissue repair was about 5%, compared to 9% for mesh-augmented repair, because mesh complications add their own surgical burden. More broadly, after native tissue prolapse repair, the risk of the prolapse descending beyond the vaginal opening again is around 10–15%, bothersome bulge symptoms recur in 10–20%, and fewer than 10% need another operation within the first couple of years.

For prolapse of the vaginal apex (the top of the vagina, or the uterus itself), native tissue suspension procedures attach the vaginal vault to strong ligaments in the pelvis. The two main options are sacrospinous ligament fixation and uterosacral ligament suspension. A meta-analysis found no significant difference between them in surgical success, anatomical outcomes, recurrence, or total complication rates. A head-to-head study did find that sacrospinous fixation caused more buttock and pelvic pain, while uterosacral suspension had slightly more intraoperative complications like bleeding, though neither difference was large enough to clearly favor one over the other. Surgeons tend to choose between them based on the specific anatomy of the prolapse and what they are most experienced with.

Autologous Graft Surgery

Some surgeons have pursued a middle path: using your own tissue as a graft to get the structural reinforcement that mesh provides without introducing a synthetic material. The two main donor sites are the rectus fascia (the tough sheath covering your abdominal muscles) and the fascia lata (a thick band of connective tissue on the outer thigh).

Rectus fascia grafts have been used in sacrocolpopexy, the abdominal procedure that traditionally relies on mesh to suspend the vaginal vault from the sacrum. A small case series of seven women who received autologous rectus fascia sacrocolpopexy or sacrohysteropexy reported durable results with no significant complications over an average of 16 months of follow-up. A separate group used rectus fascia grafts vaginally for high-stage apical prolapse and reported an anatomical success rate of about 92%, with significant improvements in symptom and quality-of-life scores at 12 months.

Fascia lata, harvested from the thigh, is another option being explored more aggressively. In a series of 34 women who received fascia lata sacrocolpopexy, prolapse symptoms resolved in every patient, with no treatment failures during follow-up. Most issues at the thigh harvest site were minor, including mild numbness and one small fluid collection. A larger study of 63 women with a longer average follow-up of 17 months reported that about 78% had complete symptom resolution, while 17% experienced treatment failure, with uterus-sparing procedures accounting for nearly half of those failures. Thigh-site side effects were common but mostly minor, including temporary numbness in over half of patients and small non-bothersome bulges at the harvest site in about a quarter. Robot-assisted versions of this surgery have also been performed with high patient satisfaction, though researchers note that long-term data on graft durability is still needed.

The appeal of autologous grafts is clear: they cannot erode or trigger a foreign-body reaction the way synthetic mesh can. The tradeoff is a second surgical site (your abdomen or thigh), which adds operating time and its own recovery. And we do not yet have the kind of 10- or 20-year outcome data that would tell us how these grafts hold up compared to mesh sacrocolpopexy over the long haul. For women who have already experienced mesh complications and need revision surgery, though, autologous graft repair has become an increasingly popular choice.

Pessaries

Not every prolapse needs surgery. Pessaries are removable silicone devices placed in the vagina to physically support the prolapsed organs, and for many women they work well enough to make surgery unnecessary. They come in various shapes, with ring pessaries and Gellhorn pessaries being the most commonly used for prolapse.

Fitting success rates are generally above 85%, and most studies report satisfaction rates in the range of 70–92% with medium-term use. Even in women with the most severe prolapse (stage IV), satisfaction exceeds 90% shortly after fitting. Ring pessaries have an advantage in that most women can insert and remove them on their own, which was the case for about 84% of ring users versus 58% with Gellhorn pessaries in one study. A study of 68 women with stage 2 or higher prolapse found that 88% successfully retained the pessary at six months, and nearly all of those women reported satisfaction and significant symptom improvement.

The main downsides are practical. You need to clean the pessary regularly, and some women find that inconvenient or uncomfortable. Common complications include vaginal discharge, erosion, and bleeding, though these are generally manageable with routine follow-up. Continuation rates fall over time. While 50–80% of women are still using their pessary at one year, long-term studies show that number drops considerably: one reported just 14% continued use at an average of seven years. Women over 65 and those who are sexually active tend to stick with pessaries longer. A risk factor for fitting failure is a short vagina or wide vaginal opening, often from prior surgery.

From a cost standpoint, pessaries are a strong starting point. A cost-effectiveness analysis found that beginning with pessary management (including women who eventually transitioned to surgery) cost roughly $10,000 per patient and achieved about 10.4 quality-adjusted months, compared to $15,000 and 11.4 quality-adjusted months for going directly to vaginal reconstructive surgery. Starting with a pessary does not burn any bridges. If it works, you have avoided surgery entirely. If it does not, you have lost nothing.

Vaginal Estrogen and Pessary Success

For postmenopausal women, vaginal estrogen cream is frequently prescribed alongside a pessary. The logic is straightforward: lower estrogen levels thin and dry out vaginal tissue, making it more vulnerable to irritation and erosion from the pessary. One study found that women who used vaginal estrogen were considerably less likely to stop using their pessary than those who did not (about 31% discontinuation versus 59%). Pain as a reason for quitting was much rarer in the estrogen group, and vaginal discharge was less common too.

That said, not every study agrees. A randomized controlled trial that specifically looked at whether vaginal estrogen reduced bacterial infections, vaginal abrasions, bleeding, or pain in pessary users found no measurable benefit. The evidence is mixed enough that many clinicians still recommend it as standard practice, reasoning that even if the data on specific complications is uncertain, the overall effect on vaginal tissue health makes the pessary more comfortable. Researchers are also developing pessaries that slowly release estrogen directly, which could simplify things by combining both functions into one device.

Pelvic Floor Muscle Training

Strengthening the pelvic floor muscles through supervised exercise programs can reduce prolapse symptoms, though the effect tends to be modest. A large multicenter randomized trial (the POPPY trial) found that women who completed individualized pelvic floor training reported significantly fewer prolapse symptoms at 12 months compared to a control group. A greater proportion also saw improvement in their prolapse stage at six months, though that difference did not quite reach statistical significance. Another trial found that about 19% of women in the training group improved by one prolapse stage, compared to 8% of controls, with ultrasound confirming that the bladder and rectum were physically lifted by a few millimeters.

A systematic review of this evidence found that the picture was inconsistent: some studies showed significant improvement in prolapse stage with training, while others found no measurable change compared to controls. Pelvic floor training is best understood as a first-line option for mild to moderate prolapse, or as a complement to other treatments rather than a standalone cure for advanced cases. It is low-risk, free, and can improve bladder and bowel control even if the prolapse itself does not fully reverse.

Colpocleisis for Older Adults

For older women with severe prolapse who are not sexually active, colpocleisis offers an entirely different philosophy. Rather than rebuilding the anatomy, the surgeon closes off most or all of the vaginal canal, essentially folding the vaginal walls together to push the prolapsed organs back into place and hold them there permanently. It is a mesh-free procedure with a short operating time and low complication rates.

Studies consistently describe colpocleisis as safe and effective in elderly patients, including those who are frail. One retrospective analysis spanning a decade concluded that colpocleisis provided durable anatomical outcomes with high satisfaction and low regret. Another study focused on frail elderly patients found that the procedure was well tolerated, with the simpler version (without hysterectomy) potentially preferable for minimizing recovery time. It also resolves urinary retention caused by the prolapse and can simplify catheter management when voiding is impaired.

The obvious limitation is permanent: vaginal intercourse is no longer possible afterward. This is a dealbreaker for many women, but for those who are not sexually active and want the lowest-risk surgical fix for advanced prolapse, colpocleisis has some of the best outcomes in pelvic floor surgery.

Weight Loss and Lifestyle Measures

Excess body weight increases pressure on the pelvic floor, and losing weight is sometimes recommended as part of conservative prolapse management. The reality is more nuanced than you might expect. A review of the evidence concluded that while the increase in abdominal pressure from obesity is the most likely mechanism linking weight to prolapse, weight loss does not appear to reverse anatomical prolapse. It may, however, reduce the bothersome symptoms associated with it.

A study specifically tracking overweight and obese women through a weight loss program found no significant improvement in prolapse symptoms at six months despite meaningful weight loss. While large reductions in body weight have been shown to reduce the extent of cystocele and rectocele on examination, this effect does not carry over to more severe grades of prolapse. The researchers suggested that the damage to pelvic floor structures caused by years of excess weight may be irreversible, and that prolapse has multiple contributing factors beyond weight alone, including collagen quality, ligament strength, and nerve function. This does not mean weight management is pointless; it is beneficial for pelvic floor health in general and may help prevent worsening. But it is not a treatment that will fix an existing prolapse.

Why Prolapse Is Hard to Fix Permanently

One reason all these approaches have meaningful recurrence rates is that prolapse is not simply a mechanical failure that you can stitch back together. The underlying connective tissue has changed at a molecular level. Studies of vaginal wall tissue from women with prolapse show progressive changes in collagen structure, including stiffer collagen fibers, altered ratios of collagen types, and disrupted collagen turnover. As prolapse worsens, these changes become more pronounced, suggesting that the tissue itself deteriorates alongside the visible descent of organs. Other research confirms that abnormalities in collagen content, structure, and breakdown are closely tied to the loss of pelvic floor support. Any repair, whether it uses mesh, your own tissue, or a graft, is working with tissue that has fundamentally weakened. That is why recurrence is a possibility with every technique.

What Researchers Are Working On

Several lines of research aim to improve on current options. Absorbable scaffolds made from a material called poly-4-hydroxybutyrate (P4HB) are designed to provide temporary support that gradually dissolves as your body grows new tissue in its place, potentially avoiding the permanent foreign-body problems of synthetic mesh. In lab testing, electrospun P4HB scaffolds showed the ability to release estrogen slowly, which could help local tissue healing. In a sheep model, these scaffolds improved tissue integration and healing compared to native tissue repair alone, though researchers caution that long-term studies are needed before any human application.

Stem cell therapy is another area of active investigation. In an animal model using rhesus macaques with induced vaginal weakness, transplanting mesenchymal stem cells into vaginal tissue promoted new blood vessel growth, smooth muscle formation, and extracellular matrix production, and improved the tissue’s mechanical strength. A separate study explored loading stem cells from fat tissue into a specially designed hydrogel that also scavenges damaging molecules at the injury site, improving cell survival and therapeutic effect in lab conditions. These are promising proof-of-concept results, but all of this work remains preclinical.

Vaginal laser treatment has attracted attention as a non-invasive option, with the idea that laser energy delivered to vaginal walls could stimulate collagen remodeling. A randomized trial comparing vaginal erbium laser to pelvic floor exercises found that both improved symptoms of mild to moderate prolapse to a similar extent, but neither effect was durable. The safety and effectiveness of laser devices for this purpose have not been established, and the FDA issued a warning in 2018 about their use for vaginal conditions. A review of the literature noted that the lack of good-quality evidence from large randomized, placebo-controlled trials is concerning, and that laser use can cause serious adverse events including vaginal burns, scarring, and chronic pain. Laser treatment for prolapse should be considered experimental at this point.

Choosing Between Xenografts and Other Biological Materials

Beyond using your own body’s tissue, some surgeons have tried cadaveric grafts (from tissue donors) and xenografts (from animal tissue, typically porcine or bovine). These avoid a second surgical site on your body, but they come with their own uncertainties. A review of grafts in pelvic reconstruction found that xenografts tend to be preferable to human tissue-bank grafts because their structural integrity is more predictable. However, how these biological materials compare to synthetics in surgical outcomes had not been well studied at the time of that review. The data remains thin, and most of the momentum in graft-based prolapse repair has shifted toward autologous tissue, where you avoid both the foreign-body risks of synthetics and the immunological uncertainties of donor tissue.